Postpartum depression (PPD) is a significant mental health issue affecting about 1 in 7 new mothers, characterized by symptoms such as persistent sadness, anxiety, and feelings of inadequacy. Hormonal changes post-childbirth, along with factors like …
Zuranolone, known as Zurzuvae, is a groundbreaking FDA-approved oral medication for postpartum depression (PPD) that can alleviate symptoms in as little as three days, with a typical treatment duration of two weeks. Unlike traditional antidepressants …
The article distinguishes between Baby Blues and Postpartum Depression (PPD), two conditions that affect new mothers. Baby Blues are temporary, mild mood swings and emotional distress occurring within the first two weeks postpartum, while PPD is a …
The article discusses the use of Topamax (topiramate) during pregnancy, highlighting its classification as a pregnancy category D drug by the FDA, which indicates potential risks to the developing fetus. Research has shown that Topamax can increase …
The article discusses the safety profile of Aimovig, a medication used for migraine treatment, during pregnancy and breastfeeding. It notes that while Aimovig blocks the calcitonin gene-related peptide (CGRP) receptor, its effects on pregnancy …
The article discusses Zulresso (brexanolone), the first FDA-approved treatment specifically for severe postpartum depression (PPD). Affecting approximately 15% of women post-childbirth, PPD can lead to serious mood disturbances and bonding issues …
The article discusses the significant risks associated with opioid use during pregnancy for both maternal health and fetal development. Pregnant women who use opioids face complications such as overdose, respiratory depression, and the development of …
The article discusses Adderall, a prescription medication used to treat ADHD and narcolepsy, and outlines important considerations for expecting mothers. Adderall, which contains amphetamine and dextroamphetamine, can have side effects such as lack …
The article discusses the significance of mental health during pregnancy, highlighting that approximately 15% of pregnant women experience depression, which can lead to adverse maternal and fetal outcomes. Zoloft, a commonly prescribed …
Vyvanse, a central nervous system stimulant, is primarily used to treat ADHD and binge eating disorder. As a prodrug, it is converted into dextroamphetamine after ingestion, allowing for controlled release and potentially reducing abuse risk. While …
The article discusses the use of Prozac (fluoxetine) during pregnancy, emphasizing the importance of consulting healthcare providers about mental health history before making decisions. Prozac, an SSRI, is effective for treating various mental health …
The article “Understanding Wellbutrin: What You Need to Know Before Pregnancy” discusses the use of Wellbutrin, a norepinephrine-dopamine reuptake inhibitor, primarily for treating major depressive disorder and seasonal affective …
Postpartum depression (PPD) is a serious mental health condition affecting many women after childbirth, marked by persistent sadness, anxiety, and exhaustion, which can hinder maternal care for both herself and her newborn. It is a common …
The article discusses Strattera, a selective norepinephrine reuptake inhibitor (NRI) used to treat ADHD, particularly when stimulant medications are ineffective or cause side effects. While it can enhance focus and impulse control, Strattera may lead …
Ubrelvy (ubrogepant) is an oral medication developed for the acute treatment of migraines, functioning as a CGRP receptor antagonist. It offers effective relief without the vasoconstrictive side effects of traditional migraine treatments like …
